Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

AVTE - Aerovate Therapeutics, Inc. Stock Price, Fair Value and News

$8.65-0.35 (-3.89%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AVTE Price Action

Last 7 days

3310.9%

Last 30 days

-90.1%

Last 90 days

-90.0%

Trailing 12 Months

-98.9%

AVTE RSI Chart

AugSepOctNovDec2025FebMarApr2030405060708090100

AVTE Valuation

Market Cap

7.2M

Price/Earnings (Trailing)

-0.15

EV/EBITDA

0.53

Price/Free Cashflow

-0.14

MarketCap/EBT

-0.1

AVTE Price/Earnings (Trailing)

2022202320242025-400-300-200-1000

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AVTE Fundamentals

AVTE Earnings

Earnings (TTM)

-49.0M

Earnings Growth (Yr)

89.14%

Earnings Growth (Qtr)

53.63%

20212022202320242025-80M-60M-40M-20M0

AVTE Profitability

Return on Equity

-65.24%

Return on Assets

-63.15%

Free Cashflow Yield

-696.65%

AVTE Investor Care

Shares Dilution (1Y)

4.28%

Diluted EPS (TTM)

-59.5

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs

About Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
 CEO
 WEBSITEhttps://aerovatetx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES43

Aerovate Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Aerovate Therapeutics, Inc.? What does AVTE stand for in stocks?

AVTE is the stock ticker symbol of Aerovate Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aerovate Therapeutics, Inc. (AVTE)?

As of Fri May 09 2025, market cap of Aerovate Therapeutics, Inc. is 7.16 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVTE stock?

You can check AVTE's fair value in chart for subscribers.

Is Aerovate Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether AVTE is over valued or under valued. Whether Aerovate Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Aerovate Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVTE.